Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
1.80
Ask:
2.00
Spread: 0.20 (11.111%)
Market Cap: £8.30m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director Dealing

19 Dec 2018 18:28

RNS Number : 0427L
Renalytix AI PLC
19 December 2018
Β 

Β 

Renalytix AI plc

Β 

("RenalytixAI" or the "Company")Β 

Β 

Β 

Director Dealing

Β 

Β 

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.

Β 

Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.

Β 

Enquiries:

Β 

Renalytix AI plc

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR or

Tel: +1 646 397 3970

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / James White / George Tzimas (Corporate Finance)

Tom Salvesen / Mia Gardner (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780

or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

Β 

Β 

Β 

Β 

Β 

Β 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Harwood Capital LLP (Harwood) as investment manager to NASCIT

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT)

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Renalytix AI Plc

b)

Β 

LEI

Β 

Β 

213800NTOH3FK3WER551

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

Β 

Identification code

GB00BYWL4Y04

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Price(s)

Volume(s)

Β 

Β 

103 pence

5,970

Β 

Β 

Β 

Β 

Β 

d)

Β 

Aggregated information

N/A

- Aggregated volume

- Price

e)

Β 

Date of the transaction

Β 

Β 

19 December 2018

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHFKCDBFBDDQBD
Date   Source Headline
14th Mar 202412:02 pmRNSForm 8 (OPD)
14th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
14th Mar 202410:42 amRNSAmendment Form 8.5 (EPT/RI) - Renalytix plc
14th Mar 20247:32 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
14th Mar 20247:00 amRNSKidneyIntelXâ„¢ included in KDIGO 2024 Guideline
13th Mar 20247:24 pmPRNForm 8.3 - Renalytix Plc
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
13th Mar 20243:22 pmPRNForm 8.3 - Renalytix Plc
13th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
13th Mar 20247:43 amGNWForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20243:31 pmRNSSuccessful completion of upsized $12m placing
12th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20247:59 amGNWForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20247:00 amRNSLaunch of equity placing of approximately US$10m
11th Mar 20245:24 pmRNSForm 8.3 - Renalytix Plc
11th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
11th Mar 20248:10 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Mar 202412:14 pmRNSFORM 8 (OPD) - Renalytix plc
8th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Mar 202410:57 amRNSForm 8.3 - Renalytix Plc
8th Mar 20247:37 amGNWForm 8.5 (EPT/RI) - Renalytix plc
7th Mar 20248:06 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
6th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
6th Mar 20247:56 amGNWForm 8.5 (EPT/RI) - Renalytix plc
5th Mar 20243:20 pmPRNForm 8.3 - Renalytix Plc
5th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Mar 20248:08 amGNWForm 8.5 (EPT/RI) - Renalytix plc
4th Mar 20241:59 pmRNSForm 8.3 - Renalytix plc
4th Mar 20247:00 amRNSApproach from Possible Strategic Acquiror
1st Mar 20246:24 pmRNSGrant of Share Options - replacement
29th Feb 20247:00 amRNSUS Government coverage expanded
15th Feb 20247:00 amRNSHalf Year Report
9th Feb 20242:00 pmRNSRenalytix to Participate in the BTIG Conference
9th Feb 20247:00 amRNSCMS publishes Draft Local Coverage Determination
17th Jan 20247:00 amRNSUpdate on kidneyIntelX.dkd LCD Consideration
10th Jan 20247:00 amRNSNew published data for KidneyIntelXâ„¢
18th Dec 20237:00 amRNSIssue of Shares
15th Dec 20236:17 pmRNSResult of AGM
8th Dec 20236:14 pmRNSDirectorate Change
23rd Nov 20237:00 amRNSGrant of Share Options
17th Nov 20233:56 pmRNSPublication of Annual Report 2023 & Notice of AGM
14th Nov 20237:00 amRNSRenalytix Reports Financial Results for Q1 FY2024
7th Nov 20237:00 amRNSNotice of Results
30th Oct 20232:37 pmRNSAnnouncement of AGM and Publication of AR
24th Oct 20237:00 amRNSDirectorate change
17th Oct 20237:00 amRNSIssue of Shares
6th Oct 20237:00 amRNSUS Patent Office Allows Patent Claims for IP
3rd Oct 20233:13 pmRNSIssue of Shares
3rd Oct 20237:00 amRNSMedicare prices kidneyintelX.dkd at $950

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.